Jian Ren

Jian Ren's work experience begins with their current role as the Director of Drug Product Analytics at Prelude Therapeutics since August 2022. Prior to this, they held the position of Associate Director of Drug Product Analytics at the same company from June 2021 to August 2022.

Before joining Prelude Therapeutics, Jian Ren worked at SunGen Pharma, which is now Praxgen Pharmaceuticals. They served as the Associate Director of QA and ARD from March 2021 to June 2021. Prior to that, they were the Manager of Analytical R&D from October 2017 to March 2021. In this role, they were responsible for project timelines, tech transfer activities, and troubleshooting analytical methods.

Jian Ren also worked at Klus Pharma Inc., which was later acquired by SunGen. They held the position of Manager of ARD from May 2017 to October 2017 and Senior Scientist of ARD from June 2015 to May 2017. During their tenure, they led analytical R&D, collaborated with CRO labs, and provided recommendations for formulation and process development.

Earlier in their career, Jian Ren worked at Kashiv Pharma LLC as a Senior Scientist from March 2014 to June 2015 and Scientist from June 2011 to March 2014. Their responsibilities included conducting analytical tests in accordance with SOPs and regulatory guidance.

Lastly, Jian Ren's work experience includes their time at New York University as a Graduate Research Assistant from September 2004 to September 2010. They developed and optimized assay methods, conducted HPLC separations and DNA sequencing, and served as a Teaching Assistant for general chemistry lab instruction.

Jian Ren's education history includes a Bachelor's degree in Chemistry from Shandong University. Additionally, they have pursued further studies at New York University, where they are currently working towards a Doctor of Philosophy (Ph.D.) in Chemistry. Specific start and end years for both degrees are not provided.